{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:28:28Z","timestamp":1792639708520,"version":"4.5.0"},"reference-count":271,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/nrcardio.2015.83","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T10:19:36Z","timestamp":1434449976000},"page":"464-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1061,"title":["Epidemiology of venous thromboembolism"],"prefix":"10.1038","volume":"12","author":[{"given":"John A.","family":"Heit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"key":"BFnrcardio201583_CR1","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1086\/316903","volume":"67","author":"JC Souto","year":"2000","unstructured":"Souto, J. C. et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am. J. Hum. Genet. 67, 1452\u20131459 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrcardio201583_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(02)07813-3","volume":"359","author":"RA Ari\u00ebns","year":"2002","unstructured":"Ari\u00ebns, R. A. et al. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Lancet 359, 667\u2013671 (2002).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR3","first-page":"328","volume":"14","author":"TB Larsen","year":"2003","unstructured":"Larsen, T. B. et al. Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. Epidemiology 14, 328\u2013332 (2003).","journal-title":"Epidemiology"},{"key":"BFnrcardio201583_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.1538-7933.2004.00660.x","volume":"2","author":"JA Heit","year":"2004","unstructured":"Heit, J. A. et al. Familial segregation of venous thromboembolism. J. Thromb. Haemost. 2, 731\u2013736 (2004).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1160\/TH12-10-0743","volume":"109","author":"B Z\u00f6ller","year":"2013","unstructured":"Z\u00f6ller, B., Ohlsson, H., Sundquist, J. & Sundquist, K. Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden. Thromb. Haemost. 109, 458\u2013463 (2013).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.thromres.2012.02.002","volume":"130","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller, B., Li, X., Sundquist, J. & Sundquist, K. A nationwide family study of pulmonary embolism: identification of high risk families with increased risk of hospitalized and fatal pulmonary embolism. Thromb. Res. 130, 178\u2013182 (2012).","journal-title":"Thromb. Res."},{"key":"BFnrcardio201583_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1365-2141.2011.08927.x","volume":"157","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller, B., Li, X., Sundquist, J. & Sundquist, K. Shared familial aggregation of susceptibility to different manifestations of venous thromboembolism: a nationwide family study in Sweden. Br. J. Haematol. 157, 146\u2013148 (2012).","journal-title":"Br. J. Haematol."},{"key":"BFnrcardio201583_CR8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","volume":"151","author":"FA Anderson Jr","year":"1991","unstructured":"Anderson, F. A. Jr et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch. Intern. Med. 151, 933\u2013938 (1991).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR9","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1001\/archinte.1997.00440360079008","volume":"157","author":"PO Hansson","year":"1997","unstructured":"Hansson, P. O., Welin, L., Tibblin, G. & Eriksson, H. Deep vein thrombosis and pulmonary embolism in the general population. 'The Study of Men Born in 1913'. Arch. Intern. Med. 157, 1665\u20131670 (1997).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/archinte.158.6.585","volume":"158","author":"MD Silverstein","year":"1998","unstructured":"Silverstein, M. D. et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch. Intern. Med. 158, 585\u2013593 (1998).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1055\/s-0037-1613887","volume":"83","author":"E Oger","year":"2000","unstructured":"Oger, E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb. Haemost. 83, 657\u2013660 (2000).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.amjmed.2004.01.018","volume":"117","author":"M Cushman","year":"2004","unstructured":"Cushman, M. et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am. J. Med. 117, 19\u201325 (2004).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201583_CR13","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1111\/j.1538-7836.2005.01415.x","volume":"3","author":"JA Heit","year":"2005","unstructured":"Heit, J. A. Venous thromboembolism: disease burden, outcomes and risk factors. J. Thromb. Haemost. 3, 1611\u20131617 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1525-1497.2006.00458.x","volume":"21","author":"FA Spencer","year":"2006","unstructured":"Spencer, F. A. et al. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J. Gen. Intern. Med. 21, 722\u2013727 (2006).","journal-title":"J. Gen. Intern. Med."},{"key":"BFnrcardio201583_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","volume":"5","author":"IA Naess","year":"2007","unstructured":"Naess, I. A. et al. Incidence and mortality of venous thrombosis: a population-based study. J. Thromb. Haemost. 5, 692\u2013699 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11239-009-0378-3","volume":"28","author":"FA Spencer","year":"2009","unstructured":"Spencer, F. A. et al. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J. Thromb. Thrombolysis 28, 401\u2013409 (2009).","journal-title":"J. Thromb. Thrombolysis"},{"key":"BFnrcardio201583_CR17","doi-asserted-by":"publisher","first-page":"832.e13","DOI":"10.1016\/j.amjmed.2013.02.024","volume":"126","author":"V Tagalakis","year":"2013","unstructured":"Tagalakis, V., Patenaude, V., Kahn, S. R. & Suissa, S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am. J. Med. 126, 832.e13\u2013832.e21 (2013).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201583_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.amjmed.2014.03.041","volume":"127","author":"W Huang","year":"2014","unstructured":"Huang, W., Goldberg, R. J., Anderson, F. A., Kiefe, C. I. & Spencer, F. A. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985\u20132009). Am. J. Med. 127, 829\u2013839.e5 (2014).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201583_CR19","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0140-6736(04)16405-2","volume":"363","author":"PM Rothwell","year":"2004","unstructured":"Rothwell, P. M. et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363, 1925\u20131933 (2004).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2014.7692","volume":"312","author":"S Koton","year":"2014","unstructured":"Koton, S. et al. Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA 312, 259\u2013268 (2014).","journal-title":"JAMA"},{"key":"BFnrcardio201583_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.7326\/0003-4819-128-9-199805010-00006","volume":"128","author":"RH White","year":"1998","unstructured":"White, R. H., Zhou, H. & Romano, P. S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann. Intern. Med. 128, 737\u2013740 (1998).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR22","first-page":"1967","volume":"98","author":"D Schneider","year":"2006","unstructured":"Schneider, D., Lilienfeld, D. E. & Im, W. The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality. J. Natl Med. Assoc. 98, 1967\u20131972 (2006).","journal-title":"J. Natl Med. Assoc."},{"key":"BFnrcardio201583_CR23","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1161\/CIRCULATIONAHA.113.006472","volume":"129","author":"NA Zakai","year":"2014","unstructured":"Zakai, N. A. et al. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation 129, 1502\u20131509 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio201583_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/bjs.4454","volume":"91","author":"BL Cheuk","year":"2004","unstructured":"Cheuk, B. L., Cheung, G. C. & Cheng, S. W. Epidemiology of venous thromboembolism in a Chinese population. Br. J. Surg. 91, 424\u2013428 (2004).","journal-title":"Br. J. Surg."},{"key":"BFnrcardio201583_CR25","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/S0002-9149(00)00766-9","volume":"85","author":"AL Klatsky","year":"2000","unstructured":"Klatsky, A. L., Armstrong, M. A. & Poggi, J. Risk of pulmonary embolism and\/or deep venous thrombosis in Asian-Americans. Am. J. Cardiol. 85, 1334\u20131337 (2000).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201583_CR26","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1160\/TH04-08-0506","volume":"93","author":"RH White","year":"2005","unstructured":"White, R. H., Zhou, H., Murin, S. & Harvey, D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb. Haemost. 93, 298\u2013305 (2005).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0049-3848(03)00058-6","volume":"108","author":"WC Hooper","year":"2002","unstructured":"Hooper, W. C., Holman, R. C., Heit, J. A. & Cobb, N. Venous thromboembolism hospitalizations among American Indians and Alaska Natives. Thromb. Res. 108, 273\u2013278 (2002).","journal-title":"Thromb. Res."},{"key":"BFnrcardio201583_CR28","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","volume":"162","author":"JA Heit","year":"2002","unstructured":"Heit, J. A. et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch. Intern. Med. 162, 1245\u20131248 (2002).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1538-7836.2004.01117.x","volume":"3","author":"JA Heit","year":"2005","unstructured":"Heit, J. A., Sobell, J. L., Li, H. & Sommer, S. S. The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study. J. Thromb. Haemost. 3, 305\u2013311 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","volume":"125","author":"P Prandoni","year":"1996","unstructured":"Prandoni, P. et al. The long-term clinical course of acute deep venous thrombosis. Ann. Intern. Med. 125, 1\u20137 (1996).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archinte.160.6.761","volume":"160","author":"JA Heit","year":"2000","unstructured":"Heit, J. A. et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch. Intern. Med. 160, 761\u2013768 (2000).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/archinte.160.6.769","volume":"160","author":"PO Hansson","year":"2000","unstructured":"Hansson, P. O., S\u00f6rbo, J. & Eriksson, H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch. Intern. Med. 160, 769\u2013774 (2000).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR33","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1001\/archinte.163.11.1285","volume":"163","author":"CJ van Dongen","year":"2003","unstructured":"van Dongen, C. J., Vink, R., Hutten, B. A., B\u00fcller, H. R. & Prins, M. H. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis. Arch. Intern. Med. 163, 1285\u20131293 (2003).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1538-7836.2006.01795.x","volume":"4","author":"S Schulman","year":"2006","unstructured":"Schulman, S. et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J. Thromb. Haemost. 4, 734\u2013742 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3324\/haematol.10516","volume":"92","author":"P Prandoni","year":"2007","unstructured":"Prandoni, P. et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 92, 199\u2013205 (2007).","journal-title":"Haematologica"},{"key":"BFnrcardio201583_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archinternmed.2007.69","volume":"168","author":"FA Spencer","year":"2008","unstructured":"Spencer, F. A. et al. Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch. Intern. Med. 168, 425\u2013430 (2008).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1160\/TH08-06-0390","volume":"100","author":"JA Nieto","year":"2008","unstructured":"Nieto, J. A. et al. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry. Thromb. Haemost. 100, 789\u2013796 (2008).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1160\/TH08-04-0238","volume":"100","author":"RH White","year":"2008","unstructured":"White, R. H., Chan, W. S., Zhou, H. & Ginsberg, J. S. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. Thromb. Haemost. 100, 246\u2013252 (2008).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR39","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/S0140-6736(10)60962-2","volume":"376","author":"PA Kyrle","year":"2010","unstructured":"Kyrle, P. A., Rosendaal, F. R. & Eichinger, S. Risk assessment for recurrent venous thrombosis. Lancet 376, 2032\u20132039 (2010).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.thromres.2012.04.003","volume":"130","author":"M Verso","year":"2012","unstructured":"Verso, M. et al. Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry. Thromb. Res. 130, 369\u2013373 (2012).","journal-title":"Thromb. Res."},{"key":"BFnrcardio201583_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJM199702063360601","volume":"336","author":"S Schulman","year":"1997","unstructured":"Schulman, S. et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N. Engl. J. Med. 336, 393\u2013398 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJM199903253401201","volume":"340","author":"C Kearon","year":"1999","unstructured":"Kearon, C. et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N. Engl. J. Med. 340, 901\u2013907 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1056\/NEJM200107193450302","volume":"345","author":"G Agnelli","year":"2001","unstructured":"Agnelli, G. et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N. Engl. J. Med. 345, 165\u2013169 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR44","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1056\/NEJM199506223322501","volume":"332","author":"S Schulman","year":"1995","unstructured":"Schulman, S. et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N. Engl. J. Med. 332, 1661\u20131665 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7326\/0003-4819-139-1-200307010-00008","volume":"139","author":"G Agnelli","year":"2003","unstructured":"Agnelli, G. et al. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann. Intern. Med. 139, 19\u201325 (2003).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR46","doi-asserted-by":"publisher","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","volume":"137","author":"P Prandoni","year":"2002","unstructured":"Prandoni, P. et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann. Intern. Med. 137, 955\u2013960 (2002).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR47","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/BF03041030","volume":"115","author":"PA Kyrle","year":"2003","unstructured":"Kyrle, P. A. & Eichinger, S. The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism. Wien. Klin. Wochenschr. 115, 471\u2013474 (2003).","journal-title":"Wien. Klin. Wochenschr."},{"key":"BFnrcardio201583_CR48","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1001\/archinte.160.22.3431","volume":"160","author":"JD Douketis","year":"2000","unstructured":"Douketis, J. D., Foster, G. A., Crowther, M. A., Prins, M. H. & Ginsberg, J. S. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch. Intern. Med. 160, 3431\u20133436 (2000).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1055\/s-0037-1613230","volume":"88","author":"S Murin","year":"2002","unstructured":"Murin, S., Romano, P. S. & White, R. H. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb. Haemost. 88, 407\u2013414 (2002).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR50","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMoa032959","volume":"350","author":"PA Kyrle","year":"2004","unstructured":"Kyrle, P. A. et al. The risk of recurrent venous thromboembolism in men and women. N. Engl. J. Med. 350, 2558\u20132563 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR51","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3324\/haematol.10967","volume":"92","author":"C Laczkovics","year":"2007","unstructured":"Laczkovics, C. et al. Risk of recurrence after a first venous thromboembolic event in young women. Haematologica 92, 1201\u20131207 (2007).","journal-title":"Haematologica"},{"key":"BFnrcardio201583_CR52","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.thromres.2008.05.009","volume":"123","author":"TM Kim","year":"2009","unstructured":"Kim, T. M. et al. Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea. Thromb. Res. 123, 436\u2013443 (2009).","journal-title":"Thromb. Res."},{"key":"BFnrcardio201583_CR53","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","volume":"168","author":"S Eichinger","year":"2008","unstructured":"Eichinger, S. et al. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch. Intern. Med. 168, 1678\u20131683 (2008).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR54","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.thromres.2006.05.013","volume":"119","author":"E Romualdi","year":"2007","unstructured":"Romualdi, E., Squizzato, A. & Ageno, W. Abdominal obesity and the risk of recurrent deep vein thrombosis. Thromb. Res. 119, 687\u2013690 (2007).","journal-title":"Thromb. Res."},{"key":"BFnrcardio201583_CR55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000088541","volume":"34","author":"MJ Garcia-Fuster","year":"2005","unstructured":"Garcia-Fuster, M. J. et al. Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years. Pathophysiol. Haemost. Thromb. 34, 6\u201312 (2005).","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"BFnrcardio201583_CR56","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/j.1538-7836.2011.04272.x","volume":"9","author":"JA Heit","year":"2011","unstructured":"Heit, J. A. et al. Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism. J. Thromb. Haemost. 9, 1133\u20131142 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR57","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1056\/NEJM200411043511919","volume":"351","author":"G Agnelli","year":"2004","unstructured":"Agnelli, G., Becattini, C. & Prandoni, P. Recurrent venous thromboembolism in men and women. N. Engl. J. Med. 351, 2015\u20132018 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","volume":"362","author":"T Baglin","year":"2003","unstructured":"Baglin, T., Luddington, R., Brown, K. & Baglin, C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 362, 523\u2013526 (2003).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR59","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1111\/j.1538-7836.2004.01050.x","volume":"2","author":"T Baglin","year":"2004","unstructured":"Baglin, T., Luddington, R., Brown, K. & Baglin, C. High risk of recurrent venous thromboembolism in men. J. Thromb. Haemost. 2, 2152\u20132155 (2004).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR60","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0140-6736(06)69110-1","volume":"368","author":"S McRae","year":"2006","unstructured":"McRae, S., Tran, H., Schulman, S., Ginsberg, J. & Kearon, C. Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet 368, 371\u2013378 (2006).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR61","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1182\/blood-2009-04-215418","volume":"114","author":"WM Lijfering","year":"2009","unstructured":"Lijfering, W. M. et al. A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. Blood 114, 2031\u20132036 (2009).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR62","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1160\/TH09-10-0685","volume":"104","author":"G Le Gal","year":"2010","unstructured":"Le Gal, G. et al. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thromb. Haemost. 104, 498\u2013503 (2010).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR63","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1111\/j.1538-7836.2010.03994.x","volume":"8","author":"SC Christiansen","year":"2010","unstructured":"Christiansen, S. C., Lijfering, W. M., Helmerhorst, F. M., Rosendaal, F. R. & Cannegieter, S. C. Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event. J. Thromb. Haemost. 8, 2159\u20132168 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR64","doi-asserted-by":"publisher","first-page":"d813","DOI":"10.1136\/bmj.d813","volume":"342","author":"J Douketis","year":"2011","unstructured":"Douketis, J. et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 342, d813 (2011).","journal-title":"BMJ"},{"key":"BFnrcardio201583_CR65","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","volume":"18","author":"BA Hutten","year":"2000","unstructured":"Hutten, B. A. et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J. Clin. Oncol. 18, 3078\u20133083 (2000).","journal-title":"J. Clin. Oncol."},{"key":"BFnrcardio201583_CR66","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1161\/01.CIR.103.20.2453","volume":"103","author":"L Pinede","year":"2001","unstructured":"Pinede, L. et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 103, 2453\u20132460 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio201583_CR67","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni, P. et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100, 3484\u20133488 (2002).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR68","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MBC.0b013e328341f030","volume":"22","author":"ML Louzada","year":"2011","unstructured":"Louzada, M. L., Majeed, H., Dao, V. & Wells, P. S. Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies. Blood Coagul. Fibrinolysis 22, 86\u201391 (2011).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"BFnrcardio201583_CR69","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.111.051920","volume":"126","author":"ML Louzada","year":"2012","unstructured":"Louzada, M. L. et al. Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. Circulation 126, 448\u2013454 (2012).","journal-title":"Circulation"},{"key":"BFnrcardio201583_CR70","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1182\/blood-2014-01-549733","volume":"123","author":"CE Chee","year":"2014","unstructured":"Chee, C. E. et al. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood 123, 3972\u20133978 (2014).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR71","first-page":"1710","volume":"170","author":"A Iorio","year":"2010","unstructured":"Iorio, A. et al. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Arch. Intern. Med. 170, 1710\u20131716 (2010).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR72","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1111\/j.1538-7836.2010.04022.x","volume":"8","author":"T Baglin","year":"2010","unstructured":"Baglin, T. et al. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J. Thromb. Haemost. 8, 2436\u20132442 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR73","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/j.1538-7836.2010.03958.x","volume":"8","author":"MJ Kovacs","year":"2010","unstructured":"Kovacs, M. J. et al. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism. J. Thromb. Haemost. 8, 1926\u20131932 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR74","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","volume":"104","author":"S Schulman","year":"1998","unstructured":"Schulman, S., Svenungsson, E. & Granqvist, S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Am. J. Med. 104, 332\u2013338 (1998).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201583_CR75","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1182\/blood-2013-04-496257","volume":"122","author":"D Garcia","year":"2013","unstructured":"Garcia, D., Akl, E. A., Carr, R. & Kearon, C. Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review. Blood 122, 817\u2013824 (2013).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR76","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/bjh.12848","volume":"165","author":"D Jayakody Arachchillage","year":"2014","unstructured":"Jayakody Arachchillage, D. & Greaves, M. The chequered history of the antiphospholipid syndrome. Br. J. Haematol. 165, 609\u2013617 (2014).","journal-title":"Br. J. Haematol."},{"key":"BFnrcardio201583_CR77","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1001\/archinte.1997.00440400077009","volume":"157","author":"AG van den Belt","year":"1997","unstructured":"van den Belt, A. G. et al. Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch. Intern. Med. 157, 2227\u20132232 (1997).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR78","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1538-7836.2005.01197.x","volume":"3","author":"CY Vossen","year":"2005","unstructured":"Vossen, C. Y. et al. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J. Thromb. Haemost. 3, 459\u2013464 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR79","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1160\/TH08-06-0364","volume":"101","author":"JL Brouwer","year":"2009","unstructured":"Brouwer, J. L. et al. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thromb. Haemost. 101, 93\u201399 (2009).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/blood-2006-04-014654","volume":"109","author":"M den Heijer","year":"2007","unstructured":"den Heijer, M. et al. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial. Blood 109, 139\u2013144 (2007).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR81","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7326\/0003-4819-149-7-200810070-00008","volume":"149","author":"M Verhovsek","year":"2008","unstructured":"Verhovsek, M. et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann. Intern. Med. 149, 481\u2013490 (2008).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR82","doi-asserted-by":"publisher","first-page":"523","DOI":"10.7326\/0003-4819-153-8-201010190-00009","volume":"153","author":"J Douketis","year":"2010","unstructured":"Douketis, J. et al. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann. Intern. Med. 153, 523\u2013531 (2010).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR83","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/blood-2009-08-237354","volume":"115","author":"B Cosmi","year":"2010","unstructured":"Cosmi, B. et al. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood 115, 481\u2013488 (2010).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR84","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1182\/blood-2014-01-548065","volume":"124","author":"G Palareti","year":"2014","unstructured":"Palareti, G. et al. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 124, 196\u2013203 (2014).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR85","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1365-2141.2011.08578.x","volume":"153","author":"M Tan","year":"2011","unstructured":"Tan, M., Mos, I. C., Klok, F. A. & Huisman, M. V. Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review. Br. J. Haematol. 153, 168\u2013178 (2011).","journal-title":"Br. J. Haematol."},{"key":"BFnrcardio201583_CR86","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1538-7836.2011.04240.x","volume":"9","author":"G Le Gal","year":"2011","unstructured":"Le Gal, G. et al. Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study. J. Thromb. Haemost. 9, 1126\u20131132 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR87","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/archinte.166.7.729","volume":"166","author":"WK Ho","year":"2006","unstructured":"Ho, W. K., Hankey, G. J., Quinlan, D. J. & Eikelboom, J. W. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch. Intern. Med. 166, 729\u2013736 (2006).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR88","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1160\/TH13-06-0488","volume":"110","author":"E G\u00e1ndara","year":"2013","unstructured":"G\u00e1ndara, E. et al. Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study. Thromb. Haemost. 110, 1172\u20131179 (2013).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR89","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/ATVBAHA.108.182428","volume":"29","author":"T Zhu","year":"2009","unstructured":"Zhu, T., Martinez, I. & Emmerich, J. Venous thromboembolism: risk factors for recurrence. Arterioscler. Thromb. Vasc. Biol. 29, 298\u2013310 (2009).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201583_CR90","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1111\/j.1538-7836.2006.02140.x","volume":"4","author":"M Cushman","year":"2006","unstructured":"Cushman, M. et al. Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. J. Thromb. Haemost. 4, 2199\u20132203 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR91","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/eurheartj\/eht046","volume":"34","author":"S Biere-Rafi","year":"2013","unstructured":"Biere-Rafi, S. et al. Statin treatment and the risk of recurrent pulmonary embolism. Eur. Heart J. 34, 1800\u20131806 (2013).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201583_CR92","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1538-7836.2010.03798.x","volume":"8","author":"RH White","year":"2010","unstructured":"White, R. H., Murin, S., Wun, T. & Danielsen, B. Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism. J. Thromb. Haemost. 8, 987\u2013997 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR93","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0002-9343(01)00661-1","volume":"110","author":"JD Douketis","year":"2001","unstructured":"Douketis, J. D., Crowther, M. A., Foster, G. A. & Ginsberg, J. S. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am. J. Med. 110, 515\u2013519 (2001).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201583_CR94","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archinte.164.1.92","volume":"164","author":"S Eichinger","year":"2004","unstructured":"Eichinger, S. et al. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch. Intern. Med. 164, 92\u201396 (2004).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR95","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1160\/TH05-10-0677","volume":"95","author":"D Jim\u00e9nez","year":"2006","unstructured":"Jim\u00e9nez, D. et al. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism. Thromb. Haemost. 95, 562\u2013566 (2006).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR96","doi-asserted-by":"publisher","first-page":"d3036","DOI":"10.1136\/bmj.d3036","volume":"342","author":"F Boutitie","year":"2011","unstructured":"Boutitie, F. et al. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. BMJ 342, d3036 (2011).","journal-title":"BMJ"},{"key":"BFnrcardio201583_CR97","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/jth.12512","volume":"12","author":"JP Galanaud","year":"2014","unstructured":"Galanaud, J. P. et al. Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. J. Thromb. Haemost. 12, 436\u2013443 (2014).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR98","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1182\/blood-2013-04-497545","volume":"122","author":"PL den Exter","year":"2013","unstructured":"den Exter, P. L. et al. Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood 122, 1144\u20131149 (2013).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR99","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1503\/cmaj.080493","volume":"179","author":"MA Rodger","year":"2008","unstructured":"Rodger, M. A. et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 179, 417\u2013426 (2008).","journal-title":"CMAJ"},{"key":"BFnrcardio201583_CR100","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","volume":"121","author":"S Eichinger","year":"2010","unstructured":"Eichinger, S., Heinze, G., Jandeck, L. M. & Kyrle, P. A. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation 121, 1630\u20131636 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio201583_CR101","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","volume":"10","author":"A Tosetto","year":"2012","unstructured":"Tosetto, A. et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J. Thromb. Haemost. 10, 1019\u20131025 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR102","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1160\/TH12-05-0353","volume":"108","author":"PA Kyrle","year":"2012","unstructured":"Kyrle, P. A. & Eichinger, S. Clinical scores to predict recurrence risk of venous thromboembolism. Thromb. Haemost. 108, 1061\u20131064 (2012).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR103","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/MCP.0b013e328363ed7c","volume":"19","author":"D Poli","year":"2013","unstructured":"Poli, D. & Palareti, G. Assessing recurrence risk following acute venous thromboembolism: use of algorithms. Curr. Opin. Pulm. Med. 19, 407\u2013412 (2013).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"BFnrcardio201583_CR104","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/jth.12192","volume":"11","author":"PL den Exter","year":"2013","unstructured":"den Exter, P. L., Kooiman, J. & Huisman, M. V. Validation of the Ottawa prognostic score for the prediction of recurrent venous thromboembolism in patients with cancer-associated thrombosis. J. Thromb. Haemost. 11, 998\u20131000 (2013).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR105","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jama.2011.2013","volume":"307","author":"JA Heit","year":"2012","unstructured":"Heit, J. A. Estimating the incidence of symptomatic postoperative venous thromboembolism: the importance of perspective. JAMA 307, 306\u2013307 (2012).","journal-title":"JAMA"},{"key":"BFnrcardio201583_CR106","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1160\/TH07-03-0212","volume":"98","author":"AT Cohen","year":"2007","unstructured":"Cohen, A. T. et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb. Haemost. 98, 756\u2013764 (2007).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR107","unstructured":"Centers for Disease Control and Prevention (CDC). Venous thromboembolism in adult hospitalizations\u2014United States, 2007\u20132009. MMWR Morb. Mortal. Wkly Rep. 61, 401\u2013404 (2012)."},{"key":"BFnrcardio201583_CR108","first-page":"e255","volume":"21","author":"KP Cohoon","year":"2015","unstructured":"Cohoon, K. P. et al. Costs of venous thromboembolism associated with hospitalization for medical illness. Am. J. Manag. Care 21, e255\u2013e263 (2015).","journal-title":"Am. J. Manag. Care"},{"key":"BFnrcardio201583_CR109","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.surg.2014.10.005","volume":"157","author":"KP Cohoon","year":"2015","unstructured":"Cohoon, K. P. et al. Direct medical costs attributable to venous thromboembolism among persons hospitalized for major surgery: a population-based longitudinal study. Surgery 157, 423\u2013431 (2015).","journal-title":"Surgery"},{"key":"BFnrcardio201583_CR110","doi-asserted-by":"crossref","unstructured":"ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J. Thromb. Haemost. 12, 1580\u20131590 (2014).","DOI":"10.1111\/jth.12698"},{"key":"BFnrcardio201583_CR111","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archinte.159.5.445","volume":"159","author":"JA Heit","year":"1999","unstructured":"Heit, J. A. et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch. Intern. Med. 159, 445\u2013453 (1999).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR112","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S0140-6736(98)07534-5","volume":"353","author":"SZ Goldhaber","year":"1999","unstructured":"Goldhaber, S. Z., Visani, L. & De Rosa, M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353, 1386\u20131389 (1999).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR113","first-page":"766","volume":"114","author":"K Janata","year":"2002","unstructured":"Janata, K. et al. Mortality of patients with pulmonary embolism. Wien. Klin. Wochenschr. 114, 766\u2013772 (2002).","journal-title":"Wien. Klin. Wochenschr."},{"key":"BFnrcardio201583_CR114","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.thromres.2011.02.017","volume":"127","author":"MS Andresen","year":"2011","unstructured":"Andresen, M. S. et al. Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy. Thromb. Res. 127, 540\u2013546 (2011).","journal-title":"Thromb. Res."},{"key":"BFnrcardio201583_CR115","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.114.009107","volume":"130","author":"KK S\u00f8gaard","year":"2014","unstructured":"S\u00f8gaard, K. K., Schmidt, M., Pedersen, L., Horv\u00e1th-Puh\u00f3, E. & S\u00f8rensen, H. T. 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation 130, 829\u2013836 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio201583_CR116","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra0907731","volume":"363","author":"G Agnelli","year":"2010","unstructured":"Agnelli, G. & Becattini, C. Acute pulmonary embolism. N. Engl. J. Med. 363, 266\u2013274 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR117","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/01.CIR.96.3.882","volume":"96","author":"S Konstantinides","year":"1997","unstructured":"Konstantinides, S. et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 96, 882\u2013888 (1997).","journal-title":"Circulation"},{"key":"BFnrcardio201583_CR118","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/archinte.163.14.1711","volume":"163","author":"KT Horlander","year":"2003","unstructured":"Horlander, K. T., Mannino, D. M. & Leeper, K. V. Pulmonary embolism mortality in the United States, 1979\u20131998: an analysis using multiple-cause mortality data. Arch. Intern. Med. 163, 1711\u20131717 (2003).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR119","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1001\/archinternmed.2012.198","volume":"172","author":"J Tsai","year":"2012","unstructured":"Tsai, J., Grosse, S. D., Grant, A. M., Hooper, W. C. & Atrash, H. K. Trends in in-hospital deaths among hospitalizations with pulmonary embolism. Arch. Intern. Med. 172, 960\u2013961 (2012).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR120","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.thromres.2010.08.010","volume":"126","author":"MK Barsoum","year":"2010","unstructured":"Barsoum, M. K. et al. Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb. Res. 126, 373\u2013378 (2010).","journal-title":"Thromb. Res."},{"key":"BFnrcardio201583_CR121","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/archinte.160.6.809","volume":"160","author":"JA Heit","year":"2000","unstructured":"Heit, J. A. et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch. Intern. Med. 160, 809\u2013815 (2000).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR122","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1182\/blood-2002-05-1416","volume":"101","author":"M Cushman","year":"2003","unstructured":"Cushman, M. et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 101, 1243\u20131248 (2003).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR123","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(06)68474-2","volume":"367","author":"L Smeeth","year":"2006","unstructured":"Smeeth, L. et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 367, 1075\u20131079 (2006).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR124","doi-asserted-by":"publisher","first-page":"b4583","DOI":"10.1136\/bmj.b4583","volume":"339","author":"S Sweetland","year":"2009","unstructured":"Sweetland, S. et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 339, b4583 (2009).","journal-title":"BMJ"},{"key":"BFnrcardio201583_CR125","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1001\/archinternmed.2008.589","volume":"169","author":"ID Bezemer","year":"2009","unstructured":"Bezemer, I. D., van der Meer, F. J., Eikenboom, J. C., Rosendaal, F. R. & Doggen, C. J. The value of family history as a risk indicator for venous thrombosis. Arch. Intern. Med. 169, 610\u2013615 (2009).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR126","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1182\/blood-2013-01-479238","volume":"121","author":"RE Roach","year":"2013","unstructured":"Roach, R. E., Lijfering, W. M., Flinterman, L. E., Rosendaal, F. R. & Cannegieter, S. C. Increased risk of CVD after VT is determined by common etiologic factors. Blood 121, 4948\u20134954 (2013).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR127","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1182\/blood-2014-06-577783","volume":"125","author":"SC Cannegieter","year":"2015","unstructured":"Cannegieter, S. C. et al. Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis: a nationwide cohort study. Blood 125, 229\u2013235 (2015).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR128","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.4065\/76.11.1102","volume":"76","author":"JA Heit","year":"2001","unstructured":"Heit, J. A. et al. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin. Proc. 76, 1102\u20131110 (2001).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrcardio201583_CR129","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1111\/j.1538-7836.2006.02196.x","volume":"4","author":"S Noboa","year":"2006","unstructured":"Noboa, S., Mottier, D., Oger, E. & EPI-GETBO Study Group. Estimation of a potentially preventable fraction of venous thromboembolism: a community-based prospective study. J. Thromb. Haemost. 4, 2720\u20132722 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR130","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","volume":"160","author":"MM Samama","year":"2000","unstructured":"Samama, M. M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch. Intern. Med. 160, 3415\u20133420 (2000).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR131","doi-asserted-by":"publisher","first-page":"381S","DOI":"10.1378\/chest.08-0656","volume":"133","author":"WH Geerts","year":"2008","unstructured":"Geerts, W. H. et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133, 381S\u2013453S (2008).","journal-title":"Chest"},{"key":"BFnrcardio201583_CR132","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.113.001428","volume":"127","author":"S Sweetland","year":"2013","unstructured":"Sweetland, S. et al. Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study. Circulation 127, 1276\u20131282 (2013).","journal-title":"Circulation"},{"key":"BFnrcardio201583_CR133","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1160\/TH03-03-0152","volume":"90","author":"RH White","year":"2003","unstructured":"White, R. H., Zhou, H. & Romano, P. S. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb. Haemost. 90, 446\u2013455 (2003).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR134","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1445-1433.2004.03258.x","volume":"74","author":"MJ Edmonds","year":"2004","unstructured":"Edmonds, M. J., Crichton, T. J., Runciman, W. B. & Pradhan, M. Evidence-based risk factors for postoperative deep vein thrombosis. ANZ J. Surg. 74, 1082\u20131097 (2004).","journal-title":"ANZ J. Surg."},{"key":"BFnrcardio201583_CR135","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.amjcard.2003.09.057","volume":"93","author":"SZ Goldhaber","year":"2004","unstructured":"Goldhaber, S. Z., Tapson, V. F. & DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am. J. Cardiol. 93, 259\u2013262 (2004).","journal-title":"Am. J. Cardiol."},{"issue":"Suppl. 6","key":"BFnrcardio201583_CR136","doi-asserted-by":"publisher","first-page":"349S","DOI":"10.1378\/chest.124.6_suppl.349S","volume":"124","author":"FA Anderson Jr","year":"2003","unstructured":"Anderson, F. A. Jr, Hirsh, J., White, K., Fitzgerald, R. H. Jr & Hip and Knee Registry Investigators. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996\u20132001: findings from the Hip and Knee Registry. Chest 124 (Suppl. 6), 349S\u2013356S (2003).","journal-title":"Chest"},{"key":"BFnrcardio201583_CR137","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1056\/NEJM200012143432403","volume":"343","author":"RH White","year":"2000","unstructured":"White, R. H., Gettner, S., Newman, J. M., Trauner, K. B. & Romano, P. S. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N. Engl. J. Med. 343, 1758\u20131764 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR138","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1161\/CIRCULATIONAHA.111.063354","volume":"125","author":"L Parkin","year":"2012","unstructured":"Parkin, L. et al. Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study. Circulation 125, 1897\u20131904 (2012).","journal-title":"Circulation"},{"key":"BFnrcardio201583_CR139","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/00000542-200309000-00009","volume":"99","author":"CB Mantilla","year":"2003","unstructured":"Mantilla, C. B., Horlocker, T. T., Schroeder, D. R., Berry, D. J. & Brown, D. L. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology 99, 552\u2013560 (2003).","journal-title":"Anesthesiology"},{"key":"BFnrcardio201583_CR140","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1111\/j.1538-7836.2004.00991.x","volume":"2","author":"NA Zakai","year":"2004","unstructured":"Zakai, N. A., Wright, J. & Cushman, M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J. Thromb. Haemost. 2, 2156\u20132161 (2004).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR141","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1538-7836.2006.01818.x","volume":"4","author":"P Chopard","year":"2006","unstructured":"Chopard, P., Spirk, D. & Bounameaux, H. Identifying acutely ill medical patients requiring thromboprophylaxis. J. Thromb. Haemost. 4, 915\u2013916 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR142","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar, S. et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J. Thromb. Haemost. 8, 2450\u20132457 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR143","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/jhm.888","volume":"6","author":"MB Rothberg","year":"2011","unstructured":"Rothberg, M. B., Lindenauer, P. K., Lahti, M., Pekow, P. S. & Selker, H. P. Risk factor model to predict venous thromboembolism in hospitalized medical patients. J. Hosp. Med. 6, 202\u2013209 (2011).","journal-title":"J. Hosp. Med."},{"key":"BFnrcardio201583_CR144","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1378\/chest.10-1944","volume":"140","author":"AC Spyropoulos","year":"2011","unstructured":"Spyropoulos, A. C. et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 140, 706\u2013714 (2011).","journal-title":"Chest"},{"key":"BFnrcardio201583_CR145","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.amjmed.2011.06.004","volume":"124","author":"SC Woller","year":"2011","unstructured":"Woller, S. C. et al. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am. J. Med. 124, 947\u2013954.e2 (2011).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201583_CR146","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jth.12147","volume":"11","author":"NA Zakai","year":"2013","unstructured":"Zakai, N. A., Callas, P. W., Repp, A. B. & Cushman, M. Venous thrombosis risk assessment in medical inpatients: the medical inpatients and thrombosis (MITH) study. J. Thromb. Haemost. 11, 634\u2013641 (2013).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR147","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.thromres.2011.09.025","volume":"129","author":"MM Samama","year":"2012","unstructured":"Samama, M. M., Combe, S., Conard, J. & Horellou, M. H. Risk assessment models for thromboprophylaxis of medical patients. Thromb. Res. 129, 127\u2013132 (2012).","journal-title":"Thromb. Res."},{"key":"BFnrcardio201583_CR148","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1001\/jamainternmed.2014.3357","volume":"174","author":"MB Rothberg","year":"2014","unstructured":"Rothberg, M. B. Venous thromboembolism prophylaxis for medical patients: who needs it? JAMA Intern. Med. 174, 1585\u20131586 (2014).","journal-title":"JAMA Intern. Med."},{"key":"BFnrcardio201583_CR149","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/archinte.166.4.458","volume":"166","author":"HK Chew","year":"2006","unstructured":"Chew, H. K., Wun, T., Harvey, D., Zhou, H. & White, R. H. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch. Intern. Med. 166, 458\u2013464 (2006).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR150","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","volume":"4","author":"JW Blom","year":"2006","unstructured":"Blom, J. W. et al. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J. Thromb. Haemost. 4, 529\u2013535 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR151","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/1097-0142(19850215)55:4<702::AID-CNCR2820550405>3.0.CO;2-N","volume":"55","author":"O Kucuk","year":"1985","unstructured":"Kucuk, O., Kwaan, H. C., Gunnar, W. & Vazquez, R. M. Thromboembolic complications associated with L-asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma. Cancer 55, 702\u2013706 (1985).","journal-title":"Cancer"},{"key":"BFnrcardio201583_CR152","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/1097-0142(19820801)50:3<451::AID-CNCR2820500312>3.0.CO;2-4","volume":"50","author":"HA Liebman","year":"1982","unstructured":"Liebman, H. A., Wada, J. K., Patch, M. J. & McGehee, W. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase. Cancer 50, 451\u2013456 (1982).","journal-title":"Cancer"},{"key":"BFnrcardio201583_CR153","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1182\/blood.V98.5.1614","volume":"98","author":"M Zangari","year":"2001","unstructured":"Zangari, M. et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 98, 1614\u20131615 (2001).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR154","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1056\/NEJMc053530","volume":"354","author":"R Knight","year":"2006","unstructured":"Knight, R., DeLap, R. J. & Zeldis, J. B. Lenalidomide and venous thrombosis in multiple myeloma. N. Engl. J. Med. 354, 2079\u20132080 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR155","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1046\/j.1365-2125.1998.00733.x","volume":"45","author":"CR Meier","year":"1998","unstructured":"Meier, C. R. & Jick, H. Tamoxifen and risk of idiopathic venous thromboembolism. Br. J. Clin. Pharmacol. 45, 608\u2013612 (1998).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BFnrcardio201583_CR156","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0140-6736(97)10018-6","volume":"351","author":"JA Baron","year":"1998","unstructured":"Baron, J. A., Gridley, G., Weiderpass, E., Nyr\u00e9n, O. & Linet, M. Venous thromboembolism and cancer. Lancet 351, 1077\u20131080 (1998).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR157","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/j.1538-7836.2004.00720.x","volume":"2","author":"A Piccioli","year":"2004","unstructured":"Piccioli, A. et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J. Thromb. Haemost. 2, 884\u2013889 (2004).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR158","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4065\/mcp.2010.0339","volume":"86","author":"AJ Tafur","year":"2011","unstructured":"Tafur, A. J. et al. The association of active cancer with venous thromboembolism location: a population-based study. Mayo Clin. Proc. 86, 25\u201330 (2011).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrcardio201583_CR159","doi-asserted-by":"publisher","first-page":"323","DOI":"10.7326\/0003-4819-149-5-200809020-00007","volume":"149","author":"M Carrier","year":"2008","unstructured":"Carrier, M. et al. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann. Intern. Med. 149, 323\u2013333 (2008).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR160","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H. & Francis, C. W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111, 4902\u20134907 (2008).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR161","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","volume":"116","author":"C Ay","year":"2010","unstructured":"Ay, C. et al. Prediction of venous thromboembolism in cancer patients. Blood 116, 5377\u20135382 (2010).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR162","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1001\/jama.286.6.700","volume":"286","author":"J Merrer","year":"2001","unstructured":"Merrer, J. et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 286, 700\u2013707 (2001).","journal-title":"JAMA"},{"key":"BFnrcardio201583_CR163","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7326\/0003-4819-152-4-201002160-00006","volume":"152","author":"H Decousus","year":"2010","unstructured":"Decousus, H. et al. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann. Intern. Med. 152, 218\u2013224 (2010).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR164","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/0002-9343(83)90805-7","volume":"74","author":"SZ Goldhaber","year":"1983","unstructured":"Goldhaber, S. Z. et al. Risk factors for pulmonary embolism. The Framingham Study. Am. J. Med. 74, 1023\u20131028 (1983).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201583_CR165","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/archinte.1994.00420020066008","volume":"154","author":"A Cogo","year":"1994","unstructured":"Cogo, A. et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch. Intern. Med. 154, 164\u2013168 (1994).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR166","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1001\/archinte.163.2.239","volume":"163","author":"JE Dalen","year":"2003","unstructured":"Dalen, J. E. Economy class syndrome: too much flying or too much sitting? Arch. Intern. Med. 163, 2674\u20132676 (2003).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR167","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1371\/journal.pmed.0040290","volume":"4","author":"S Kuipers","year":"2007","unstructured":"Kuipers, S. et al. The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations. PLoS Med. 4, e290 (2007).","journal-title":"PLoS Med."},{"key":"BFnrcardio201583_CR168","doi-asserted-by":"publisher","first-page":"180","DOI":"10.7326\/0003-4819-151-3-200908040-00129","volume":"151","author":"D Chandra","year":"2009","unstructured":"Chandra, D., Parisini, E. & Mozaffarian, D. Meta-analysis: travel and risk for venous thromboembolism. Ann. Intern. Med. 151, 180\u2013190 (2009).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR169","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2141.2010.08408.x","volume":"152","author":"HG Watson","year":"2011","unstructured":"Watson, H. G. & Baglin, T. P. Guidelines on travel-related venous thrombosis. Br. J. Haematol. 152, 31\u201334 (2011).","journal-title":"Br. J. Haematol."},{"key":"BFnrcardio201583_CR170","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/archinte.161.11.1405","volume":"161","author":"JG Ray","year":"2001","unstructured":"Ray, J. G. et al. Use of statins and the subsequent development of deep vein thrombosis. Arch. Intern. Med. 161, 1405\u20131410 (2001).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR171","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1472-8206.2004.00252.x","volume":"18","author":"K Lacut","year":"2004","unstructured":"Lacut, K. et al. Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study. Fundam. Clin. Pharmacol. 18, 477\u2013482 (2004).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"BFnrcardio201583_CR172","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","volume":"360","author":"RJ Glynn","year":"2009","unstructured":"Glynn, R. J. et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N. Engl. J. Med. 360, 1851\u20131861 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR173","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1161\/01.ATV.0000143134.87051.46","volume":"24","author":"CJ Doggen","year":"2004","unstructured":"Doggen, C. J. et al. Serum lipid levels and the risk of venous thrombosis. Arterioscler. Thromb. Vasc. Biol. 24, 1970\u20131975 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201583_CR174","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa022157","volume":"348","author":"P Prandoni","year":"2003","unstructured":"Prandoni, P. et al. An association between atherosclerosis and venous thrombosis. N. Engl. J. Med. 348, 1435\u20131441 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR175","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.amjmed.2003.06.005","volume":"115","author":"R Marcucci","year":"2003","unstructured":"Marcucci, R. et al. Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism. Am. J. Med. 115, 601\u2013605 (2003).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201583_CR176","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","volume":"162","author":"AW Tsai","year":"2002","unstructured":"Tsai, A. W. et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch. Intern. Med. 162, 1182\u20131189 (2002).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR177","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(07)61745-0","volume":"370","author":"HT S\u00f8rensen","year":"2007","unstructured":"S\u00f8rensen, H. T., Horvath-Puho, E., Pedersen, L., Baron, J. A. & Prandoni, P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 370, 1773\u20131779 (2007).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR178","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1093\/eurheartj\/ehr223","volume":"32","author":"B Z\u00f6ller","year":"2011","unstructured":"Z\u00f6ller, B., Li, X., Sundquist, J. & Sundquist, K. Venous thromboembolism does not share strong familial susceptibility with coronary heart disease: a nationwide family study in Sweden. Eur. Heart J. 32, 2800\u20132805 (2011).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201583_CR179","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.thromres.2014.06.033","volume":"134","author":"MK Barsoum","year":"2014","unstructured":"Barsoum, M. K. et al. Are myocardial infarction and venous thromboembolism associated? Population-based case-control and cohort studies. Thromb. Res. 134, 593\u2013598 (2014).","journal-title":"Thromb. Res."},{"key":"BFnrcardio201583_CR180","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.amjmed.2007.10.008","volume":"121","author":"AR Folsom","year":"2008","unstructured":"Folsom, A. R. & Chamberlain, A. Lipoprotein(a) and venous thromboembolism. Am. J. Med. 121, e17 (2008).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201583_CR181","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1182\/blood-2008-05-157412","volume":"112","author":"AM Chamberlain","year":"2008","unstructured":"Chamberlain, A. M., Folsom, A. R., Heckbert, S. R., Rosamond, W. D. & Cushman, M. High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE). Blood 112, 2675\u20132680 (2008).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR182","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/0003-4819-128-6-199803150-00008","volume":"128","author":"L Chasan-Taber","year":"1998","unstructured":"Chasan-Taber, L. & Stampfer, M. J. Epidemiology of oral contraceptives and cardiovascular disease. Ann. Intern. Med. 128, 467\u2013477 (1998).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR183","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1055\/s-0037-1614648","volume":"82","author":"FR Rosendaal","year":"1999","unstructured":"Rosendaal, F. R. Risk factors for venous thrombotic disease. Thromb. Haemost. 82, 610\u2013619 (1999).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR184","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","volume":"164","author":"MP Gomes","year":"2004","unstructured":"Gomes, M. P. & Deitcher, S. R. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch. Intern. Med. 164, 1965\u20131976 (2004).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR185","doi-asserted-by":"publisher","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","volume":"132","author":"D Grady","year":"2000","unstructured":"Grady, D. et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen\/progestin Replacement Study. Ann. Intern. Med. 132, 689\u2013696 (2000).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR186","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/jama.1997.03550060053030","volume":"278","author":"D Grady","year":"1997","unstructured":"Grady, D., Hulley, S. B. & Furberg, C. Venous thromboembolic events associated with hormone replacement therapy. JAMA 278, 477 (1997).","journal-title":"JAMA"},{"key":"BFnrcardio201583_CR187","doi-asserted-by":"publisher","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","volume":"143","author":"JA Heit","year":"2005","unstructured":"Heit, J. A. et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann. Intern. Med. 143, 697\u2013706 (2005).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR188","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1160\/TH07-07-0468","volume":"99","author":"J Adomaityte","year":"2008","unstructured":"Adomaityte, J., Farooq, M. & Qayyum, R. Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis. Thromb. Haemost. 99, 338\u2013342 (2008).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR189","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","volume":"30","author":"A van Hylckama Vlieg","year":"2010","unstructured":"van Hylckama Vlieg, A., Helmerhorst, F. M. & Rosendaal, F. R. The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device. Arterioscler. Thromb. Vasc. Biol. 30, 2297\u20132300 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201583_CR190","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/jama.292.13.1581","volume":"292","author":"NL Smith","year":"2004","unstructured":"Smith, N. L. et al. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 292, 1581\u20131587 (2004).","journal-title":"JAMA"},{"key":"BFnrcardio201583_CR191","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/ATVBAHA.109.184127","volume":"29","author":"AH James","year":"2009","unstructured":"James, A. H. Venous thromboembolism in pregnancy. Arterioscler. Thromb. Vasc. Biol. 29, 326\u2013331 (2009).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201583_CR192","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1067\/mob.2001.107919","volume":"184","author":"DR Danilenko-Dixon","year":"2001","unstructured":"Danilenko-Dixon, D. R. et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am. J. Obstet. Gynecol. 184, 104\u2013110 (2001).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrcardio201583_CR193","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1182\/blood-2013-07-518159","volume":"122","author":"RE Roach","year":"2013","unstructured":"Roach, R. E. et al. The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors. Blood 122, 4264\u20134269 (2013).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR194","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1182\/blood-2012-11-469551","volume":"121","author":"AA Sultan","year":"2013","unstructured":"Sultan, A. A. et al. Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom. Blood 121, 3953\u20133961 (2013).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR195","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-2141.2007.06766.x","volume":"139","author":"JF Ludvigsson","year":"2007","unstructured":"Ludvigsson, J. F., Welander, A., Lassila, R., Ekbom, A. & Montgomery, S. M. Risk of thromboembolism in 14,000 individuals with coeliac disease. Br. J. Haematol. 139, 121\u2013127 (2007).","journal-title":"Br. J. Haematol."},{"key":"BFnrcardio201583_CR196","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1378\/chest.08-2830","volume":"135","author":"E Shantsila","year":"2009","unstructured":"Shantsila, E., Lip, G. Y. & Chong, B. H. Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. Chest 135, 1651\u20131664 (2009).","journal-title":"Chest"},{"key":"BFnrcardio201583_CR197","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/ajh.10287","volume":"72","author":"AW Tsai","year":"2003","unstructured":"Tsai, A. W. et al. Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE). Am. J. Hematol. 72, 192\u2013200 (2003).","journal-title":"Am. J. Hematol."},{"key":"BFnrcardio201583_CR198","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","volume":"3","author":"M den Heijer","year":"2005","unstructured":"den Heijer, M., Lewington, S. & Clarke, R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J. Thromb. Haemost. 3, 292\u2013299 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR199","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1182\/blood-2009-11-253724","volume":"115","author":"B van Zaane","year":"2010","unstructured":"van Zaane, B. et al. Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood 115, 4344\u20134349 (2010).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR200","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2141.2010.08418.x","volume":"152","author":"MT Severinsen","year":"2011","unstructured":"Severinsen, M. T. et al. Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Br. J. Haematol. 152, 360\u2013362 (2011).","journal-title":"Br. J. Haematol."},{"key":"BFnrcardio201583_CR201","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1182\/blood-2012-12-467068","volume":"121","author":"S Boyle","year":"2013","unstructured":"Boyle, S., White, R. H., Brunson, A. & Wun, T. Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia. Blood 121, 4782\u20134790 (2013).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR202","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","volume":"375","author":"MJ Grainge","year":"2010","unstructured":"Grainge, M. J., West, J. & Card, T. R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375, 657\u2013663 (2010).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR203","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1182\/blood-2008-12-196014","volume":"113","author":"F Dentali","year":"2009","unstructured":"Dentali, F. et al. JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood 113, 5617\u20135623 (2009).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR204","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","volume":"115","author":"T Barbui","year":"2010","unstructured":"Barbui, T. et al. Thrombosis in primary myelofibrosis: incidence and risk factors. Blood 115, 778\u2013782 (2010).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR205","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1093\/ndt\/gfq179","volume":"25","author":"AR Folsom","year":"2010","unstructured":"Folsom, A. R. et al. Chronic kidney disease and venous thromboembolism: a prospective study. Nephrol. Dial. Transplant. 25, 3296\u20133301 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrcardio201583_CR206","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.amjmed.2007.08.042","volume":"121","author":"F Kayali","year":"2008","unstructured":"Kayali, F., Najjar, R., Aswad, F., Matta, F. & Stein, P. D. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am. J. Med. 121, 226\u2013230 (2008).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201583_CR207","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1182\/asheducation-2008.1.111","volume":"2008","author":"RA Brodsky","year":"2008","unstructured":"Brodsky, R. A. Paroxysmal nocturnal hemoglobinuria: stem cells and clonality. Hematology Am. Soc. Hematol. Educ. Program 2008, 111\u2013115 (2008).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"BFnrcardio201583_CR208","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/art.33322","volume":"64","author":"AK Bacani","year":"2012","unstructured":"Bacani, A. K., Gabriel, S. E., Crowson, C. S., Heit, J. A. & Matteson, E. L. Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum. 64, 53\u201361 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrcardio201583_CR209","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/2012.jama.11741","volume":"308","author":"ME Holmqvist","year":"2012","unstructured":"Holmqvist, M. E. et al. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA 308, 1350\u20131356 (2012).","journal-title":"JAMA"},{"key":"BFnrcardio201583_CR210","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1001\/jama.287.20.2655","volume":"287","author":"I Arnulf","year":"2002","unstructured":"Arnulf, I. et al. Obstructive sleep apnea and venous thromboembolism. JAMA 287, 2655\u20132656 (2002).","journal-title":"JAMA"},{"key":"BFnrcardio201583_CR211","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.thromres.2014.06.009","volume":"134","author":"YH Peng","year":"2014","unstructured":"Peng, Y. H. et al. Association between obstructive sleep apnea and deep vein thrombosis \/ pulmonary embolism: a population-based retrospective cohort study. Thromb. Res. 134, 340\u2013345 (2014).","journal-title":"Thromb. Res."},{"key":"BFnrcardio201583_CR212","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1182\/blood-2006-11-057604","volume":"110","author":"H Austin","year":"2007","unstructured":"Austin, H. et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 110, 908\u2013912 (2007).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR213","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","volume":"142","author":"PA Merkel","year":"2005","unstructured":"Merkel, P. A. et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann. Intern. Med. 142, 620\u2013626 (2005).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR214","first-page":"3702","volume":"94","author":"BJ Sanson","year":"1999","unstructured":"Sanson, B. J. et al. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood 94, 3702\u20133706 (1999).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR215","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ajh.10229","volume":"71","author":"AR Folsom","year":"2002","unstructured":"Folsom, A. R., Cushman, M., Tsai, M. Y., Heckbert, S. R. & Aleksic, N. Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism. Am. J. Hematol. 71, 285\u2013290 (2002).","journal-title":"Am. J. Hematol."},{"key":"BFnrcardio201583_CR216","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/j.1538-7836.2005.01312.x","volume":"3","author":"CY Vossen","year":"2005","unstructured":"Vossen, C. Y. & Rosendaal, F. R. The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level. J. Thromb. Haemost. 3, 1102\u20131103 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR217","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1161\/01.ATV.0000174806.76629.7b","volume":"25","author":"CY Vossen","year":"2005","unstructured":"Vossen, C. Y. et al. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arterioscler. Thromb. Vasc. Biol. 25, 1992\u20131997 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201583_CR218","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1160\/TH03-05-0329","volume":"91","author":"T Bombeli","year":"2004","unstructured":"Bombeli, T., Piccapietra, B., Boersma, J., Fehr, J. Decreased anticoagulant response to tissue factor pathway inhibitor in patients with venous thromboembolism and otherwise no evidence of hereditary or acquired thrombophilia. Thromb. Haemost. 91, 80\u201386 (2004).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR219","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1172\/JCI111317","volume":"73","author":"GJ Broze Jr","year":"1984","unstructured":"Broze, G. J. Jr & Miletich, J. P. Human Protein Z. J. Clin. Invest. 73, 933\u2013938 (1984).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio201583_CR220","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1073\/pnas.120081897","volume":"97","author":"ZF Yin","year":"2000","unstructured":"Yin, Z. F. et al. Prothrombotic phenotype of protein Z deficiency. Proc. Natl Acad. Sci. USA 97, 6734\u20136738 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio201583_CR221","doi-asserted-by":"publisher","first-page":"9250","DOI":"10.1073\/pnas.95.16.9250","volume":"95","author":"X Han","year":"1998","unstructured":"Han, X., Fiehler, R. & Broze, G. J. Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc. Natl Acad. Sci. USA 95, 9250\u20139255 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio201583_CR222","doi-asserted-by":"publisher","first-page":"11073","DOI":"10.1021\/bi990641a","volume":"38","author":"X Han","year":"1999","unstructured":"Han, X., Huang, Z. F., Fiehler, R. & Broze, G. J. Jr. The protein Z-dependent protease inhibitor is a serpin. Biochemistry 38, 11073\u201311078 (1999).","journal-title":"Biochemistry"},{"key":"BFnrcardio201583_CR223","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1182\/blood-2004-06-2250","volume":"105","author":"M Souri","year":"2005","unstructured":"Souri, M., Koseki-Kuno, S., Iwata, H., Kemkes-Matthes, B. & Ichinose, A. A naturally occurring E30Q mutation in the Gla domain of protein Z causes its impaired secretion and subsequent deficiency. Blood 105, 3149\u20133154 (2005).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR224","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1182\/blood-2005-05-2180","volume":"106","author":"S Uitte de Willige","year":"2005","unstructured":"Uitte de Willige, S. et al. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Blood 106, 4176\u20134183 (2005).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR225","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.5858\/2002-126-1304-CUOFVL","volume":"126","author":"RD Press","year":"2002","unstructured":"Press, R. D., Bauer, K. A., Kujovich, J. L. & Heit, J. A. Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch. Pathol. Lab. Med. 126, 1304\u20131318 (2002).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrcardio201583_CR226","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1182\/blood.V99.8.2720","volume":"99","author":"AR Folsom","year":"2002","unstructured":"Folsom, A. R. et al. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood 99, 2720\u20132725 (2002).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR227","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/0003-4819-140-5-200403020-00008","volume":"140","author":"K Juul","year":"2004","unstructured":"Juul, K., Tybjaerg-Hansen, A., Schnohr, P. & Nordestgaard, B. G. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann. Intern. Med. 140, 330\u2013337 (2004).","journal-title":"Ann. Intern. Med."},{"key":"BFnrcardio201583_CR228","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.5858\/2002-126-1405-EHFLAP","volume":"126","author":"WL Chandler","year":"2002","unstructured":"Chandler, W. L., Rodgers, G. M., Sprouse, J. T. & Thompson, A. R. Elevated hemostatic factor levels as potential risk factors for thrombosis. Arch. Pathol. Lab. Med. 126, 1405\u20131414 (2002).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrcardio201583_CR229","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1111\/j.1538-7836.2003.0543b.x","volume":"1","author":"A van Hylckama Vlieg","year":"2003","unstructured":"van Hylckama Vlieg, A. & Rosendaal, F. R. High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly. J. Thromb. Haemost. 1, 2677\u20132678 (2003).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR230","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1160\/TH05-01-0013","volume":"93","author":"PS Wells","year":"2005","unstructured":"Wells, P. S., Langlois, N. J., Webster, M. A., Jaffey, J. & Anderson, J. A. Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada\u2014is it necessary to define a new upper reference range for factor VIII? Thromb. Haemost. 93, 842\u2013846 (2005).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR231","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.5858\/2002-126-1319-CALMOT","volume":"126","author":"RC McGlennen","year":"2002","unstructured":"McGlennen, R. C. & Key, N. S. Clinical and laboratory management of the prothrombin G20210A mutation. Arch. Pathol. Lab. Med. 126, 1319\u20131325 (2002).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrcardio201583_CR232","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","volume":"345","author":"T Koster","year":"1995","unstructured":"Koster, T., Blann, A. D., Bri\u00ebt, E., Vandenbroucke, J. P. & Rosendaal, F. R. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345, 152\u2013155 (1995).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR233","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(95)90689-4","volume":"345","author":"PK MacCallum","year":"1995","unstructured":"MacCallum, P. K. et al. Clotting factor VIII and risk of deep-vein thrombosis. Lancet 345, 804 (1995).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR234","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-0037-1613747","volume":"83","author":"RA Kraaijenhagen","year":"2000","unstructured":"Kraaijenhagen, R. A. et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb. Haemost. 83, 5\u20139 (2000).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR235","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1538-7836.2004.01033.x","volume":"3","author":"I Bank","year":"2005","unstructured":"Bank, I. et al. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. J. Thromb. Haemost. 3, 79\u201384 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR236","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1182\/blood.V95.12.3678","volume":"95","author":"A van Hylckama Vlieg","year":"2000","unstructured":"van Hylckama Vlieg, A., van der Linden, I. K., Bertina, R. M. & Rosendaal, F. R. High levels of factor IX increase the risk of venous thrombosis. Blood 95, 3678\u20133682 (2000).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR237","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1056\/NEJM200003093421004","volume":"342","author":"JC Meijers","year":"2000","unstructured":"Meijers, J. C., Tekelenburg, W. L., Bouma, B. N., Bertina, R. M. & Rosendaal, F. R. High levels of coagulation factor XI as a risk factor for venous thrombosis. N. Engl. J. Med. 342, 696\u2013701 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201583_CR238","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1538-7836.2007.02579.x","volume":"5","author":"T Ohira","year":"2007","unstructured":"Ohira, T. et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J. Thromb. Haemost. 5, 1455\u20131461 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR239","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2009-05-219915","volume":"114","author":"M Cushman","year":"2009","unstructured":"Cushman, M., O'Meara, E. S., Folsom, A. R. & Heckbert, S. R. Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood 114, 2878\u20132883 (2009).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR240","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","volume":"121","author":"NL Smith","year":"2010","unstructured":"Smith, N. L. et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation 121, 1382\u20131392 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio201583_CR241","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.1182\/blood-2008-11-190389","volume":"113","author":"DA Tr\u00e9gou\u00ebt","year":"2009","unstructured":"Tr\u00e9gou\u00ebt, D. A. et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 113, 5298\u20135303 (2009).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR242","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1182\/blood-2011-12-397752","volume":"120","author":"HG de Haan","year":"2012","unstructured":"de Haan, H. G. et al. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood 120, 656\u2013663 (2012).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR243","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/ATVBAHA.112.248161","volume":"32","author":"W Cohen","year":"2012","unstructured":"Cohen, W. et al. ABO blood group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia. Arterioscler. Thromb. Vasc. Biol. 32, 2021\u20132028 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201583_CR244","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/j.1538-7836.2012.04810.x","volume":"10","author":"JA Heit","year":"2012","unstructured":"Heit, J. A. et al. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J. Thromb. Haemost. 10, 1521\u20131531 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR245","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/gepi.21731","volume":"37","author":"W Tang","year":"2013","unstructured":"Tang, W. et al. A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genet. Epidemiol. 37, 512\u2013521 (2013).","journal-title":"Genet. Epidemiol."},{"key":"BFnrcardio201583_CR246","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1182\/blood-2004-03-1042","volume":"104","author":"A Tripodi","year":"2004","unstructured":"Tripodi, A., Chantarangkul, V., Martinelli, I., Bucciarelli, P. & Mannucci, P. M. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 104, 3631\u20133634 (2004).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR247","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0895-4356(03)00052-0","volume":"56","author":"AR Folsom","year":"2003","unstructured":"Folsom, A. R., Cushman, M., Heckbert, S. R., Rosamond, W. D. & Aleksic, N. Prospective study of fibrinolytic markers and venous thromboembolism. J. Clin. Epidemiol. 56, 598\u2013603 (2003).","journal-title":"J. Clin. Epidemiol."},{"key":"BFnrcardio201583_CR248","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1182\/blood-2004-08-3253","volume":"105","author":"T Lisman","year":"2005","unstructured":"Lisman, T., de Groot, P. G., Meijers, J. C. & Rosendaal, F. R. Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 105, 1102\u20131105 (2005).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR249","doi-asserted-by":"publisher","first-page":"13835","DOI":"10.1073\/pnas.250475997","volume":"97","author":"P Andr\u00e9","year":"2000","unstructured":"Andr\u00e9, P., Hartwell, D., Hrachovinov\u00e1, I., Saffaripour, S. & Wagner, D. D. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc. Natl Acad. Sci. USA 97, 13835\u201313840 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio201583_CR250","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1538-7836.2004.00689.x","volume":"2","author":"PH Reitsma","year":"2004","unstructured":"Reitsma, P. H. & Rosendaal, F. R. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J. Thromb. Haemost. 2, 619\u2013622 (2004).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR251","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1161\/01.CIR.101.13.1546","volume":"101","author":"JC Souto","year":"2000","unstructured":"Souto, J. C. et al. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101, 1546\u20131551 (2000).","journal-title":"Circulation"},{"key":"BFnrcardio201583_CR252","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0140-6736(00)03541-8","volume":"357","author":"M de Lange","year":"2001","unstructured":"de Lange, M., Snieder, H., Ari\u00ebns, R. A., Spector, T. D. & Grant, P. J. The genetics of haemostasis: a twin study. Lancet 357, 101\u2013105 (2001).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR253","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1538-7933.2003.00592.x","volume":"2","author":"CY Vossen","year":"2004","unstructured":"Vossen, C. Y. et al. Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. J. Thromb. Haemost. 2, 242\u2013247 (2004).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR254","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2141.2004.05275.x","volume":"128","author":"PE Morange","year":"2005","unstructured":"Morange, P. E. et al. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort. Br. J. Haematol. 128, 91\u201399 (2005).","journal-title":"Br. J. Haematol."},{"issue":"Suppl. 1","key":"BFnrcardio201583_CR255","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/jth.12233","volume":"11","author":"PE Morange","year":"2013","unstructured":"Morange, P. E. & Tr\u00e9gou\u00ebt, D. A. Current knowledge on the genetics of incident venous thrombosis. J. Thromb. Haemost. 11 (Suppl. 1), 111\u2013121 (2013).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR256","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1111\/j.1538-7836.2006.02119.x","volume":"4","author":"E Oren","year":"2006","unstructured":"Oren, E., Smith, N. L., Doggen, C. J., Heckbert, S. R. & Lemaitre, R. N. Body mass index and the risk of venous thrombosis among postmenopausal women. J. Thromb. Haemost. 4, 2273\u20132275 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR257","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2141.2010.08086.x","volume":"149","author":"MT Severinsen","year":"2010","unstructured":"Severinsen, M. T. et al. Genetic susceptibility, smoking, obesity and risk of venous thromboembolism. Br. J. Haematol. 149, 273\u2013279 (2010).","journal-title":"Br. J. Haematol."},{"key":"BFnrcardio201583_CR258","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","volume":"344","author":"JP Vandenbroucke","year":"1994","unstructured":"Vandenbroucke, J. P. et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344, 1453\u20131457 (1994).","journal-title":"Lancet"},{"key":"BFnrcardio201583_CR259","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1160\/TH04-11-0759","volume":"94","author":"O Wu","year":"2005","unstructured":"Wu, O. et al. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thromb. Haemost. 94, 17\u201325 (2005).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR260","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","volume":"139","author":"ER Pomp","year":"2007","unstructured":"Pomp, E. R., le Cessie, S., Rosendaal, F. R. & Doggen, C. J. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br. J. Haematol. 139, 289\u2013296 (2007).","journal-title":"Br. J. Haematol."},{"key":"BFnrcardio201583_CR261","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1046\/j.1538-7836.2003.00406.x","volume":"1","author":"A van Hylckama Vlieg","year":"2003","unstructured":"van Hylckama Vlieg, A. & Rosendaal, F. R. Interaction between oral contraceptive use and coagulation factor levels in deep venous thrombosis. J. Thromb. Haemost. 1, 2186\u20132190 (2003).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrcardio201583_CR262","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1182\/blood-2011-03-345678","volume":"118","author":"EF van Vlijmen","year":"2011","unstructured":"van Vlijmen, E. F. et al. Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception. Blood 118, 2055\u20132061 (2011).","journal-title":"Blood"},{"key":"BFnrcardio201583_CR263","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1055\/s-0037-1613085","volume":"87","author":"I Martinelli","year":"2002","unstructured":"Martinelli, I. et al. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb. Haemost. 87, 791\u2013795 (2002).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR264","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/01.ATV.0000018301.91721.94","volume":"22","author":"DM Herrington","year":"2002","unstructured":"Herrington, D. M. et al. Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease. Arterioscler. Thromb. Vasc. Biol. 22, 1012\u20131017 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201583_CR265","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1046\/j.0007-1048.2002.03356.x","volume":"116","author":"FR Rosendaal","year":"2002","unstructured":"Rosendaal, F. R. et al. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br. J. Haematol. 116, 851\u2013854 (2002).","journal-title":"Br. J. Haematol."},{"key":"BFnrcardio201583_CR266","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","volume":"292","author":"M Cushman","year":"2004","unstructured":"Cushman, M. et al. Estrogen plus progestin and risk of venous thrombosis. JAMA 292, 1573\u20131580 (2004).","journal-title":"JAMA"},{"key":"BFnrcardio201583_CR267","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/archinternmed.2007.5","volume":"168","author":"KJ van Stralen","year":"2008","unstructured":"van Stralen, K. J., Rosendaal, F. R. & Doggen, C. J. Minor injuries as a risk factor for venous thrombosis. Arch. Intern. Med. 168, 21\u201326 (2008).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201583_CR268","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1055\/s-0037-1614410","volume":"81","author":"TL Lindahl","year":"1999","unstructured":"Lindahl, T. L., Lundahl, T. H., Nilsson, L. & Andersson, C. A. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee\u2014a prospective study. Thromb. Haemost. 81, 18\u201321 (1999).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201583_CR269","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/01.blo.0000192366.61616.81","volume":"441","author":"EA Salvati","year":"2005","unstructured":"Salvati, E. A. et al. The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty. Clin. Orthop. Relat. Res. 441, 40\u201355 (2005).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"BFnrcardio201583_CR270","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"293","author":"JW Blom","year":"2005","unstructured":"Blom, J. W., Doggen, C. J., Osanto, S. & Rosendaal, F. R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293, 715\u2013722 (2005).","journal-title":"JAMA"},{"key":"BFnrcardio201583_CR271","first-page":"1068","volume":"87","author":"EJ Libourel","year":"2002","unstructured":"Libourel, E. J. et al. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor andlipoprotein(a) to the absolute risk of venous thromboembolism. Haematologica 87, 1068\u20131073 (2002).","journal-title":"Haematologica"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2015.83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2015.83","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2015.83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T13:23:07Z","timestamp":1691760187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":271,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFnrcardio201583"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2015.83","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,16]]},"assertion":[{"value":"16 June 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}